Mbadamba ọrịa mamịrị: ka esi were ma ego ole ka ọgwụ ahụ na-eri?

Diabeton bụ ọgwụ hypoglycemic sitere na otu nke usoro dị iche iche nke sulfonylurea nke ọgbọ nke abụọ, nke emepụtara n'ụdị mbadamba maka nchịkwa ọnụ. Isi ihe dị iche site na ọgwụ ndị yiri ya bụ ọnụnọ nke nwere heterocyclic mgbanaka N-nwere nke njikọ endocyclic.

Diabeton MV bụ usoro dị ogologo, ọ ga-adị obere obere oge ọ nwere ike dochie ọtụtụ usoro nke usoro ntọhapụ ọkọlọtọ.

Na ụdị shuga mellitus nke 2, Diabeton na-amalite mmalite nke insulin site na pancreas na nzaghachi maka mmụba shuga dị n'ọbara, na mgbakwunye, na-agbanwe usoro nke abụọ nke insulin. Mmụba dị ukwuu na mmepụta insulin na-apụta na azịza oriri na glucose na-abanye n'ọbara.

Akụrụngwa nọ n'ọrụ - Gliclazide - nwere ọrụ ọgwụgwọ abụọ, gosipụtara metabolic, akụrụngwa akwara na antioxidant. Ihe na-arụ ọrụ Diabeton na-abawanye uru nke anụ ahụ dị na insulin.

Diabeton MV 60 mg, foto nke ọgwụ

Mgbe ị theụsịrị ọgwụ ahụ, ọnụọgụ anụ ahụ na insulin na-abawanye site na 32%, nnabata glucose na akwara dị mma - nke a na-eme ka ikike ịchịkwa shuga ọbara na ọrịa mellitus nke ukwuu. A kọwara mmetụta nke gliclazide site n'eziokwu ahụ na ọ na - enyere insulin aka ime ihe na muscle glycogen synthetase ma na - akpali mgbanwe mgbanwe post-transcriptal na GLUT4 n'ihe metụtara glucose.

Diabeton 60 mg nke ọma na -ebelata shuga ọbara n'ihi mkpali nke insulin na -akpata site na mkpụrụ ndụ nke pancreas. N'ime ndị ọrịa nwere ụdị ọrịa shuga 2, ọgwụ ahụ na-ebido mmalite nke insulin insulin ma na-eme ka ọpụpụ nke abụọ nke mmepụta insulin, nke a na-agbanye na ọrịa shuga.

Mgbe ị theụsịrị ọgwụ ahụ, ihe ahụ na-arụ ọrụ na-akpali akụkụ nke cellular nke Langerhans, nke yiri ya na pancreas. Ozokwa, mbadamba oria 60 mg na - egbochi mgbochi ọbara n’ime akwara ọbara, ebe ọbara ji nwayọ nwayọ nwayọ.

E gosipụtaghị na ọrịa mamịrị na-akpata oke ibu n'ihi na ọgwụ a na-emetụta mmalite kachasị elu nke imepụta insulin ma ọ dịghị akpata hyperinsulinemia. N'aka nke ọzọ, ọgwụ na-enyere aka belata oke ibu na ndị ọrịa buru ibu, n'ezie, na nri kwesịrị ekwesị.

N'ọtụtụ oge, otu ọgwụ kwa ụbọchị nke Diabeton MB na-enye nnabata ọgwụgwọ zuru oke nke ihe arụ ọrụ n'ime ọbara ruo awa iri abụọ na anọ, ma nwee ike dochie usoro abụọ nke ọgwụ ahụ.

Ihe ngosi maka ojiji

Isi ihe na-egosi ị takingụ ọrịa mamịrị bụ ụdị ọrịa shuga mellitus 2 (DM) na mgbochi nke nsogbu ya.

• Ọrịa shuga 2dị nke abụọ na-arịa ọrịa shuga na-adịghị arụ ọrụ site na nri, mmega ahụ na ịta ahụ,
• mgbochi nke nsogbu nke ụdị shuga nke 2 metụtara glucose ọbara dị elu.

Ntuziaka maka iji Diabeton 60 mg, usoro onunu ogwu

Emere ọgwụ a maka naanị ndị okenye.

Abetbọchị ị selectionụ ọgwụ Diabeton ga-emerịrị dị ka ọgụgụ nke ọkwa glucose dị n'ọbara n'oge ịmalite ị .ụ ọgwụ. Enwere ike ịmalite mmụba nwayọ na usoro ọgwụgwọ ma ọ dịkarịa ala ụbọchị iri na anọ ị ofụ ọgwụ ọjọọ ahụ.

Omenala mbido bụ 30 mg kwa ụbọchị (1/2 mbadamba mamịrị 60 mg.).

A na-ahọrọ usoro onunu ogwu kwesịrị ekwesị kpamkpam, dịka ndị na-egosi glucose n'ọbara yana gluu nke HbA1C glycated. Ọ bụrụ na usoro izizi ezughi oke, ha na-agaghari na Diabeton 60 mg (mbadamba ụrọ) na gaba. Oge dị n’etiti ịbawanye usoro onunu ogwu kwesịrị ịbụ opekata mpe izu abụọ, jiri nlezianya nyochaa ọkwa shuga.

Oke kachasị bụ 120 mg kwa ụbọchị.

Ọrịa mamịrị ekwekọ na ọgwụ shuga ndị ọzọ. Enwere ike dochie otu mbadamba mamịrị 60 nke Diabeton 60 mg. Mgbe ị na-ebufe onye ọrịa site na ọgwụ Diabeton 60 mg na Diabeton MB, ọ dị mkpa ijikwa ọkwa glucose nke mita ahụ ọtụtụ ugboro n'ụbọchị.

Ọ bụrụ n’otu ọgwụ ị orụ otu ọgwụ ma ọ bụ karịa ga-efu gị, ịnweghị ike ị aụ ọgwụ dị elu na usoro ọzọ, a ga-ewere usoro ahụ echere n'echi ya. N'okwu dị mfe - esila sistemụ nnabata pụọ, ma ọ bụrụ na agbaghara gị - were naanị usoro ọgwụgwọ ọzọ dị ka usoro ahụ si dị. Enweghi okpukpu abụọ nke doses ma ọ bụ prema ugboro ugboro!

Maka ndị agadi (ihe karịrị afọ 65), ịchọghị mgbazi nke usoro ahụ ma ọ bụ usoro ọgwụgwọ ya.

N'ime ndị ọrịa nwere nsogbu gbasara akụrụ dị ntakịrị ma ọ bụ na-adịghị ala ala, a na-ede ọgwụ ahụ n'otu usoro ahụ dịka ndị ọrịa nwere ọrụ gbasara ọrụ nkịtị. Ọnwụnwa ndị ụlọ ọgwụ enyochala nnwale ndị dị otú ahụ.

Ngwurugwu mgbochi na nsonaazụ ya

Isi contraindications nke ọgwụ:

• Onwe onye na onye na-arụ ọrụ na-arụ ọrụ (gliclazide ma ọ bụ akụkụ ọ bụla nke ọgwụ ahụ.
• Ọrịa shuga mellitus (ụdị 1), ọkachasị ụmụaka, keto-acidosis, usoro ịrịa ọrịa mamịrị,
• Oria hepatic ma ọ bụ akwara siri ike,
• Usoro ọgwụgwọ Miconazole

A na - enyefe ọrịa mamịrị maka iji ya mee n'oge afọ ime na mgbe a na-enye nwa ara.

Ihe mejupụtara ọgwụ a bụ lactose, ya mere, a naghị akwado Diabeton maka ndị ọrịa nwere ọrịa lactose anabataghị, galactosemia, glucose-galactose malabsorption.

A naghị atụ aro ka iji ọgwụ a jikọta ya na phenylbutazone ma ọ bụ danazole.

Dodoụbiga ya ókè

Ihe mgbaàmà kachasị nke oke oria shuga bụ hypoglycemia (oke ịda shuga dị ala).

N'ọnọdụ ndị siri ike (ya na enweghị mmerụ ahụ), nchịkwa intravense ozugbo nke usoro hypertonic dextrose (glucose) nke 40% dị mkpa.

Nsonaazụ

Ntụziaka maka ịrịa ọrịa mamịrị na-akọwa nsonaazụ ndị a:

• Ọrịa ọgbụgba dị iche iche: ọgbụgbọ, afọ ọsịsa, ọgbụgbọ, mgbu afọ, afọ ntachi, n’ọnọdụ ndị a na-adịghị ahụkebe, cholestatic jaundice,
• Ọgba aghara nke akwara obi: thrombocytopenia, anaemia, agranulocytosis ma ọ bụ leukopenia,
• Ntughari azu nke enzymes imeju (ALT, AST, alkaline phosphatase), ịba ọcha n'anya (adịkarịghị), hyponatremia
• Mmeghachi omume nfụkasị dị iche iche (dịka nyocha nke ndị ọrịa mamịrị - adịkarịghị ezu),
• Ọrịa nkwarụ na-adị obere oge, ọkachasị na mbido ọgwụ,
• Hypoglycemia.

Ọ ga-ekwe omume ibelata ike hypoglycemic nke Diabeton site na barbiturates, diuretics dị iche iche (thiazide, ethaclates acid, furosemide), progestogens, diphenin, estrogens, rifampicins, glucocorticosteroids.

Analogs Diabeton, ndepụta ọgwụ

Enwere ike dochie mamịrị na analogues ndị a, ndepụta ọgwụ:

1. Vero-Glyclazide,
2. Glidiab MV,
3. Glisid
4. Gliclazide
5. Glioral
6. Glucostabil,
7. Diabest
8. Diabefarm
9. Diabinax
10. Diabresid
11. Medoclacid
12. Predian
13. Ntugharị.

Ọ dị mkpa ịghọta na ntuziaka maka Diabeton, ọnụahịa na nyocha anaghị emetụta analogues, enweghị ike iji ya dịka nduzi maka iji ọgwụ eji eme ihe ma ọ bụ mmetụta yiri ya. Oge ọ bụla dọkịta ga-eme ọgwụgwọ, kwesịrị inwe dọkịta. Mgbe ị na-eji dochie dochie Diabeton, ọ dị mkpa ịgakwuru onye ọkachamara, ị nwere ike ịgbanwe usoro ọgwụgwọ, usoro ọgwụgwọ, wdg.

Ejila onwe gi ogwu - o na egbu ndu!

Pharmacodynamics na pharmacokinetics

Isi, ihe na-arụ ọrụ bụ gliclazide. Ọgwụ hypoglycemic sitere na ọgbọ nke abụọ nke sulfonylurea. Glyclazide bụ usoro sitere na sulfonylurea. O nwere mgbanaka azobicyclooctane, nke na-egosipụta oke ihe dị iche na sistemu ya sitere na biguanides na -akpata mmanụ na sulfonamides.

Ọgwụ nwekwara hemovascular, metabolic na antioxidant emereme. N'okpuru mmetụta nke Ọrịa mamịrị, nchịkọta nke glucose n'ọbara na-ebelata (n'ihi nrụpụta insulin na-emepụta site na mkpụrụ ndụ beta nke puru iche).

Na ndị ọrịa na- ọrịa shuga ụdị ọgwụ nke abụọ na-eweghachite ọnụ ọgụgụ mbido mbụ na mmepụtainsulin, ma mee ka usoro insulin na-esochi pụta. Mmụba nke insulin na-eme tupu nri ma ọ bụ ibu glucose.

Antioxidant na hemovascular mmetụta ọgwụ ọjọọ na-ebelata ohere nke ọrịa shuga. Ọrịa mamịrị na-egbochi microthrombosis n'ihi mgbochi nke nchịkọta, platelet adhesion, mbelata ọnụ ọgụgụ ihe mgbaàmà platelet.

Ọgwụ ahụ na-abawanye ọrụ nke tPa, na-emetụta ọrụ fibrinolytic nke mgbidi endothelial nke arịa ahụ.

A na-enweta mmetụta antioxidant nke glycazide site na mbenata ịta peroxide lipids n'ọbara plasma, ụba ọrụ nke erythrocyte dismutase, plasma thiols, mụbara ike antioxidant zuru oke.

Gliclazide bụ metabolized n'ime imeju.

Ihe ngbanwe

Ọrịa mamịrị ketoacidosisụdị 1 ọrịa shuga mellitus, nnukwu ọrịa nke akụrụngwa akwara na ọrịa ịba ọcha n'anya, precca shuga, Comaime.

N'iji nlezianya mee ya, a na-edenye Diabeton maka ndị agadi, mgbe agbachara ya ọkụ. Anaghị etinye aka na ọgwụ ụmụaka.

Nsonaazụ

Site na nri adịghị mma, a na-achọpụta imebi usoro usoro usoro onunu ogwu hypoglycemiaagụụ, ike gwụrụ, isi ọwụwa, ọsụsọ, ngwa ngwa nkuchi obiehighi ura nchegbuime ihe ike, nleghara anya, nkwarụ anya,paresis, ịma jijijiịda mba, akpachapụghị anya, aphasia, nsogbu ọgba aghara, ụjọ ọgụ, hyperomnia, ogwe.

Ọkpụkpụ afọ: nsị dyspeptik, cholestatic jaundice, agụụ belatara, ịba ụba nke enzymes imeju.

Ahụhụ Hematopoietic: mgbochi nke ụmị ọkpụkpụ.

Dodoụbiga ya ókè

Mmetụta uche, hypoglycemia, Coma.

Ọ dị mkpa iwebata 40% hypertonic dextrose solution, were shuga n'ime, 2 mg glucagon.

Nyochaa ọbara ọbara kwa nkeji 15. Rie nri nke nwere carbohydrates (ngwa ngwa digestible).

Mmekorita

Ihe mgbochi H2-histamine na-egbochi ihe mgbochi, ACE inhibitors, NSAIDs, fibrates, antifungal ọgwụ, coumarin anticoagulants, MAO inhibitors, steroid anabolic, sulfonamides, biguanides, cyclophosphamides, pentoxifyllinetheophylline tetracycline, reserpine, nnupụisi, insulinethanol, allopurinol welie mmetụta nke Ọrịa mamịrị.

GKS, mgbochi ego, antiepileptik, adrenostimulants, BMKK, thiazide diuretics, triamteren, furosemide, baclofendiazoxide, asparaginase, triamteren, morphine, isoniazidterbutaline, ritodrin, glucagon, salbutamol, rifampicin, estrogenschlorpromazine nicotinic acid mee ka mmetụta nke ọgwụ gharazie isi ike.

Ntụziaka pụrụ iche

Site na mkpokọ ọrịa shuga, usoro ịwa ahụ, insulin oriri kwesịrị ịtụle. Mgbe ị na-eji ethanol, ihe ize ndụ nke ịmalite hypoglycemia na-abawanye.

Site na mmetụta mmetụta uche, anụ ahụ, ọ dị mkpa iji dozie dose nke ọgwụ mamịrị.

Ndị okenye, ndị ọrịa nwere ọrịa pituitary-adrenal insurance na-elebara ọgwụ hypoglycemic anya.

Na-agbadata ọsọ nke mmeghachi omume psychomotor.

Diabeton analogues

Enwere ike ịkpọ Analogues nke ọgwụ ahụ ego: Glidia, Glykinorm, Pịa, Gliclazide, Glioral, Diagnizide, Diazide, Ihe a na-akpọ Panmicron, Ntugharị.

Nyocha ndị ọrịa mamịrị

Ejiri ọgwụ a ka ọ bụrụ ihe eji arụ ọrụ dị ala maka iwetulata ọkwa shuga dị ala, ọ dị mfe iji ma e jiri ya tụnyere inje insulin. Achọpụtabeghị mmetụta ndị dị n'akụkụ ya, ọ nwere ike ọ gaghị adabara ndị ọrịa niile.

Nyocha nke ndị ọrịa mamịrị na-ewu ahụ na-akọwa ọgwụ dịka otu esi eme ka ịba ụba. Agbanyeghị, ndị dọkịta anaghị akwado iji ọgwụ ma, karịchaa, Diabeton abụghị maka ebumnuche ha. Nke a nwere ike ibute nsogbu ahụike. Ojiji nke ọgwụ nwere ike ibute hypoglycemia.

Ojiji nke sulfonylureas na ọgwụgwọ

A na-ele ọgwụ ọgwụ otu anya dị ka otu n'ime ndị kasị mma hypoglycemic elekọta iji chịkwaa ọbara shuga.

Isi ụzọ nke ọgwụgwọ kwesịrị iru ihe mgbaru ọsọ ndị a:

• mkpali nke insulin homonụ nke insulin
• belata insulin insenseitivity nke sel клеток
• nkwusi nke glucose yana jiri nwayọ wedata ya banye n'ọbara site na eriri afọ
• mmezi nke ibilite imebi ihe ruru ụmụ irighiri akwara ndị dị na ọbara.

Dabere na ogo na ọdịdị nke mmepe nke usoro pathological, ndị ọkachamara n'ịgwọ ọrịa depụtara ojiji nke ọgwụ kwesịrị ekwesị site na otu ma ọ bụ otu dị iche iche n'otu oge. Ngwunye nke sulfonylureas nwere ike ịghọ otu n'ime ọgwụ ndị dị otú ahụ.

Sulfonylurea bụ ihe hypoglycemic nke a na-eme site na sulfamide ma ejiri ya rụọ ọrụ na-agwọ ọrịa shuga. Mainzọ kachasị arụmọrụ nke ọgwụ ndị dị etu a bụ iji kpalie mkpụrụ ndụ beta pancreatic dị ndụ imepụta oke insulin chọrọ. N'ihi nsonaazụ a, ọ bụghị naanị mmepụta nke homonụ na-eme, kamakwa mmetụta nke akwara anụ ahụ maka ya na-abawanye nke ukwuu.

Na mgbakwunye, nsonaazụ ọma nke ọgwụ ọgwụ sulfonylurea bụ:

1. Dịkwuo mmetụta insulin, nke na-eduga n'inwekwu ọrụ ike na ọkwa shuga.
2. Ha na-ewepụ ọrụ nke enzymes nke na-emebi insulin dị ugbu a.
3. Mee ka ọnụ ọgụgụ ndị na - anabata insulin na membranes cell.
4. Ọfụma emetụta usoro nke glucose n'iji sel sel.
5. Ha na - eme ka mmịkọta na mkpo glucose.

A na-enyekarị ndị mmadụ ọgwụ dị etu a, ha anaghị arịa oke oke ibu.

A na-edota usoro sulfonyl n'ụdị ọgwụ nke ọgbọ atọ.

Ọgwụ nke izizi na-ejighị na usoro ahụike ọgbara ọhụrụ, ebe ha nwere mmetụta na-egbu egbu na ahụ mmadụ

Ọgbọ nke abụọ, nke dị nchebe, yabụ ejiri ya rụọ ọrụ na-agwọ ọrịa. Ihe ndi di ike dika gliclazide, nke bu akuku nke ndi oria Diabeton.

Ọgwụ nke atọ, nke nwere mmetụta nwa oge ma na-enye gị ohere ị drugsụ ọgwụ shuga dị ala na usoro dị ala iji nweta nsonaazụ achọrọ.

Isi ihe ha ji arụ ọrụ bụ glimepiride.

Gịnị bụ ọgwụ na-ebelata shuga?

Ọgwụ Diabeton bụ ọgwụ hypoglycemic, nke a gụnyere n'òtù sulfonide nke ọgbọ nke abụọ.

Ndabere nke ihe mejupụtara ya bụ gliclazide nọ n'ọrụ, n'ihi mmetụta dị mkpa nke iburu mbadamba ndị ahụ.

N'adịghị ka ọgwụ sulfonylurea ndị ọzọ (dịka ọmụmaatụ, Glibenclamide), Diabeton nwere mmetụta hypoglycemic dị ala, nke na-emetụta microcirculation, hemostasis, data hematological na njirimara nke ọbara. Ọ bụ ihe ndị a dị oke mkpa maka ndị ọrịa nwere ọrịa shuga nke ụdị shuga 2.

Ọgwụ Diabeton na-akpali mmalite nke insulin insulin, nke a na - akụghasị maka mmepe nke usoro pathological. Na mgbakwunye, akụrụngwa nke ọgwụ ahụ gụnyere:

• agụkọta na nchịkọta platelet
• ụba ọrụ nke anụ ahụ na-eme ka ọ bụrụ plasminogen na prekallikreinꓼ
• neutralization nke ihe ize ndụ nke ọbara clotsꓼ
• mbelata nke nrụgide oxidative na mmepụta nke ụmụ irighiri ihe na-anakpo
• mbelata nke ọnụọgụ propoherogenic alfa tumo necrosis ihe, n’ihi nke enwere ọrụ nchebe gbasara mmepe nke ọrịa obi na nsogbu na ọbara ọgbụgba na-arịa ọria mamịrị.
• ịgbalite usoro fibrinolysis.

Na mgbakwunye, maka Diabeton, ntuziaka maka ojiji na-egosi na ọgwụ ahụ nwere ọ bụghị naanị hypoglycemic onwunwe, kamakwa nwere njigide ọbara, metabolic na antioxidant. Ihe njikwa ọgwụ dị otú a nwere ike ịkwụsị ihe egwu dị iche iche na-eme n'ihi ọrịa shuga.

Nso idiọn̄ọ ke enye odu?

A na-enye ndị ọrịa ọgwụ Diabeton n'ụlọ ahịa ọgwụ obodo ma ọ bụrụ na enwere ndenye ọgwụ nke dọkịta na-aga.

Ọkachamara ọkachamara n'ịrịa ọrịa na-ekpebi na ọ dị mkpa iji usoro ọgwụgwọ agwọ ọrịa site na iji ọgwụ.

N'adịghị ka ọgwụ si na ìgwè biguanide (dị ka Metformin), a naghị eji Diabeton maka iwelata ibu. Ọzọkwa, ụfọdụ ndị ọrịa na-a thisụ ọgwụ a chọpụtara na mmụba dị n'ibu ha n'oge ọgwụgwọ.

Dabere na nkọwapụta banyere ọgwụ a, isi ihe na-egosi maka iji ọgwụ a bụ:

1. Mmepe nke ọrịa shuga mellitus nke ụdị insulin na-enweghị onwe ya dị ka monotherapy ma ọ bụ dịka ọgwụgwọ siri ike. Ọtụtụ mgbe, usoro ndị a na - amalite iji usoro sulfonyl na - amalite iji usoro ọgwụgwọ anaghị agwọ ọgwụ (na - eso usoro nri na mmega ahụ dị mkpa) arụpụtaghị nsonaazụ achọrọ
2. Iji wepu ihe egwu na ebumnuche mgbochi, iji gbochie ngosipụta nke nsogbu dị iche iche na-adịghị mma nke ụzọ nke ọrịa shuga na-ebu.

Nke mbu, iji ogwu a ga - egbochi oke nsogbu nke micro-vaskụla pathologies, dịka retinopathy na nephropathy, yana ọrịa ndị ọzọ nke usoro obi - nkụchi ma ọ bụ ọnya afọ.

Ntuziaka maka iji ọgwụ ahụ

Ọgwụ Diabeton dị n'ụdị mbadamba.

N'otu oge ahụ, ihe mejupụtara ọgwụ ahụ gụnyere milligram iri asatọ nke ihe mejupụtara.

A na-ewere mbadamba mamịrị dịka iwu siri ike nke otu ọkachamara ahụike si dị.

Dịka iwu, usoro ọgwụgwọ ị aụ ọgwụ si na iwu ndị a:

• ị theụ ọgwụ otu ugboro n'ụbọchị n'agbanyeghị nribata oriri (ekwesịrị ịnye ya oge ụtụtụ) ꓼ
• A na-a capụ ọgwụ ndị na-arịa ọrịa shuga mmiri n'ọnụ ya
• ubochi ubochi ka edobere n’otu nari nke milligrams iri asatọ n’ọrụ nwere ike ime ka o nwekwuo mmụba ma ọ bụrụ na ọ dị mkpa, mgbe ị na - amalite usoro ọgwụgwọ na - apụta naanị n ’iji obere opekempe, nke edobere n’otu mbadamba ọgwụ.
• Ọ bụ dọkịta na-elegara onye ọrịa ọ bụla kwesịrị ịcribedụ ya maka ọgwụ ọ bụla, na-eburu n'uche njirimara nke ụzọ ọrịa ahụ, afọ onye ọrịa na ọkwa hypoglycemiaꓼ
• iwepu ihe omume ndi ozo, mgbe ị na-egwu ọgwụ ọzọ, ikwesighi ịbawanye ụba nke ihe nọ n'ọrụ oge ọzọ ị na-ejiꓼ
• oke onodu ogwu eji eme ka okpukpo okpukpo gafee oge ekwesighi igafe mg mg ato, ya bu, mbadamba ihe anọ, ebe odi nkpa nara otutu ogwu kwesiri ka agbakwunye na onu ogugu n’inye ya n ’ubochi. dibia).

N'ọnọdụ ụfọdụ, enwere ọgwụgwọ ọgwụ, nke gụnyere ị medicationsụ ọgwụ site na klas dị iche iche.

Yabụ, mmetụta ọgwụ niile n’arụ onye ọrịa na-abawanye.

Enwere ike iji mbadamba hypoglycemic na njikọ ọgwụ na ọgwụ ndị sitere na ìgwè biguanide, alfa glucosidase inhibitors, ma ọ bụ ọgwụ insulin. Ọgwụ zuru oke nwere ike belata ihe egwu dị iche iche, yana ịhazi oke mmanwụ na glucose ọbara.

Ekwesịrị iburu n'uche na ị medicationụ ọgwụ karịrị ọgwụ ole a tụrụ aro nwere ike ibute mmepe nke hypoglycemia.

N'ihi ya, mgbe ọ na-eme ọgwụgwọ, onye ọrịa ahụ kwesịrị ịnwale oke nke shuga dị n'ọbara.

Kedu ihe ọghọm dị n’ị usingụ ọgwụ?

Dị ka ọtụtụ ọgwụ, Diabeton nwere mmetụta na contraindications.

Ọ bụrụ na agbasoghị ọgwụ ahụike yana ịba ụba ọgwụ ị ,ụ ọgwụ, enwere ike ịhụ njupụta nke Ọrịa mamịrị.

Ihe ịtụnanya a na - eduga na ọnọdụ nke akpịrị shuga, mmụọ adịghị ọcha na oke hypoglycemia. Iji wepu akara nke oke ịdoụbiga mmanya ókè, ọ dị mkpa iwebata onye ọrịa usoro ọgwụgwọ hypertonic dextrose (na mkpokọta pasent iri anọ) yana usoro glucagon, ma kwekwa ka e were ntakịrị shuga.

A na-atụ aro ka elelee ọkwa glucose ọbara kwa nkeji iri na ise. Mmetụta ọzọ na-adịghị mma nke ịdoụbiga ihe ókè bụ ohere nke isi ụbụrụ. N'okwu a, ndị dọkịta depụtara Dexamethasone na Mannitol dịka ọgwụgwọ.

Okwesiri iburu n’obi na amachibidoro ogwu iji ya gosiputa onodu ufodu na ihe.

Diabeton contraindications nwere ihe ndị a:

1. Ngosipụta nke ketoacidosis nke ụdị ọrịa mamịrị.
2. Formdị dabere na insulin nke mmepe usoro.
3. Ọrịa siri ike nke anụ ahụ dịka akụrụ na umeji.
4. Ọnụnọ nke coly glycemic na ọnọdụ nna nna.
5. N’oge ime ime na inye nwa ara.
6. Ọ bụrụ na onye ọrịa enwetala nnukwu ọkụ nke na-adịghị ala ala ma ọ bụ nnukwu nsogbu.
7. Na nwata na ndị ọrịa agadi.
8. Na ọnụnọ nke ntinye nke onye ọ bụla ma ọ bụ karịa n'ime ọgwụ ahụ.

Na mgbakwunye, na mmalite usoro ọgwụgwọ, ọ dị mkpa iji nyochaa ọdịmma mmadụ na ọnọdụ ahụike, ebe ọ bụ na ngosipụta dị iche iche na-esite n'akụkụ akụkụ ahụ na sistemụ nwere ike ịmalite. Nke mbu, ị kwesiri ị paya ntị na ọnụnọ nke mmeghachi ahụ nfụkasị, na n'ọnọdụ nke ngosipụta ha, kwụsịrị ị .ụ ọgwụ.

Na mgbakwunye, isi mmetụta ndị dị na ị takingụ ọgwụ na-agụnye:

• ọbara shuga dị ala n'okpuru ọkwa a na-anabata ya
• ịba ụba ma ọ bụ enweghị agụụ, ibu ibu
• ike ọgwụgwụ nke anụ ahụ na ike nke ikeꓼ
• ịꓼụbiga mmanya ókè
• tachycardiaꓼ
• nsogbu anya
• nsogbu ihi ụra na ehighị ụra nke ọma
• mmetụta ụjọ na-enweghị isi, ụjọ ahụ ma ọ bụ mgbakasị ahụꓼ
• anya cramps na akwara nke nwa ehi
• nsogbu erughi ya
• ụba enzymesꓼ bred
• hyperomnia.

Ọ bụrụ na enwere mmeghachi omume na-adịghị mma, ọ dị mkpa ịgwa ndị dibịa bekee banyere nke a iji were usoro ndị dị mkpa ma ọ bụ dochie ọgwụ.

Kedu ọgwụ m nwere ike iji dochie ọgwụ?

Ọgwụ sayensị ọgbara ọhụrụ na-enye ọtụtụ echiche ndị na-egosi na iji ọgwụ eme ihe n'ụzọ dị ogologo oge ga-eduga mbibi nwayọ nke mkpụrụ ndụ beta pancreatic ma nwee ike itinye aka na mmepe nke ọrịa shuga na-akpata mellitus.

N'okwu a, n'agbanyeghị ebubo ndị dị otú a, ndị dọkịta na-aga n'ihu na-eji ọgwụ agwọ ọrịa ọrịa.

Banyere Diabeton, nyocha ndị ọrịa dị iche iche. Peoplefọdụ ndị mmadụ na-ekwu na ọgwụ a dị oke mma ma dịkwa mfe ịnagide, ebe ndị ọzọ na-ewe iwe n'ihi enweghị nsonaazụ ya na mmụba dị ukwuu na oke mgbe ọgwụgwọ gasịrị.

Ikwesighi iwe nyocha niile gbasara Diabeton nke ọma, maka na mkpụrụ ndụ ọ bụla bụ nke ya, ihe ọzọ adabaghị na otu onye nwere ike ịdị mma maka onye ọzọ.

Ọnụ ego ọgwụ n’ahịa dị ihe dị ka narị atọ rubles. Ọ bụrụ na ọ dị mkpa, dibia na-abịa ga-eji dochie usoro analog dochie ọgwụ ahụ.

Kpụrụ mkpụrụ osisi jeneriki gụnyere ọgwụ ndị dị ka:

Niile ọgwụ analogue dị n’elu bụ nke otu usoro sulfonyl nke ọgbọ nke abụọ. Ọdịiche ha dị na ụlọ ọrụ na-emepụta (ụfọdụ bụ ndị nnọchi anya nke ụlọ ọrụ ọgwụ mba ọzọ, a na-emepụta ụfọdụ na Russian Federation), ọnụ ahịa na ọnụ ọgụgụ nke mmetụta ndị ọzọ, contraindications.

Enyere ozi na Diabeton na vidiyo ahụ n'isiokwu a.